SELLAS Life Sciences Group, Inc. (SLS)

4.15 +0.04 (+0.97%) USD  |  NASDAQ  |  Jan 13, 16:00
4.10 -0.05 (-1.20%) After-Hours: 20:00
More

SELLAS Life Sciences Group Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade